[go: up one dir, main page]

WO2004015416A3 - Methods for the identification of agents with anti-microbial action - Google Patents

Methods for the identification of agents with anti-microbial action Download PDF

Info

Publication number
WO2004015416A3
WO2004015416A3 PCT/EP2003/008145 EP0308145W WO2004015416A3 WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3 EP 0308145 W EP0308145 W EP 0308145W WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3
Authority
WO
WIPO (PCT)
Prior art keywords
agents
identification
methods
microbial action
eukaryotic cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/008145
Other languages
German (de)
French (fr)
Other versions
WO2004015416A2 (en
Inventor
Gerald Kleymann
Hans-Otto Werling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to AU2003255282A priority Critical patent/AU2003255282A1/en
Publication of WO2004015416A2 publication Critical patent/WO2004015416A2/en
Publication of WO2004015416A3 publication Critical patent/WO2004015416A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a novel method and the use thereof for the discovery of novel anti-microbial agents, characterised in that potential agents are simultaneously incubated with eukaryotic cells and non-viral microbes in a test composition, the viability of the eukaryotic cells is determined and subsequently those agents are selected for which the signal for the corresponding test composition is significantly larger than the mean value of the infection control at at least one concentration of the agent.
PCT/EP2003/008145 2002-08-06 2003-07-24 Methods for the identification of agents with anti-microbial action Ceased WO2004015416A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003255282A AU2003255282A1 (en) 2002-08-06 2003-07-24 Methods for the identification of agents with anti-microbial action

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002135967 DE10235967B4 (en) 2002-08-06 2002-08-06 Method for identifying substances with antimicrobial activity
DE10235967.9 2002-08-06

Publications (2)

Publication Number Publication Date
WO2004015416A2 WO2004015416A2 (en) 2004-02-19
WO2004015416A3 true WO2004015416A3 (en) 2004-05-06

Family

ID=30775043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/008145 Ceased WO2004015416A2 (en) 2002-08-06 2003-07-24 Methods for the identification of agents with anti-microbial action

Country Status (3)

Country Link
AU (1) AU2003255282A1 (en)
DE (1) DE10235967B4 (en)
WO (1) WO2004015416A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822260D0 (en) * 2008-12-05 2009-01-14 Merten Christoph Assay
GEP20207128B (en) 2016-04-06 2020-07-10 Molecules Gm Innovative Aminothiazole derivatives useful as antiviral agents
KR102708082B1 (en) 2017-10-05 2024-09-19 이노베이티브 몰리큘스 게엠베하 Enantiomers of substituted thiazoles as antiviral compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US5501959A (en) * 1989-01-17 1996-03-26 Alamar Biosciences Laboratory, Inc. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
US6046021A (en) * 1995-04-12 2000-04-04 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
WO2001000209A1 (en) * 1999-06-29 2001-01-04 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
WO2001081920A2 (en) * 2000-04-20 2001-11-01 Biolog, Inc. Comparative phenotype analysis for assessment of biologically active compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255318B1 (en) * 1997-12-11 2001-07-03 Biochem Pharma Inc. Antiviral compounds
GB9908195D0 (en) * 1999-04-09 1999-06-02 Microbiological Res Authority Treatment of intracellular infection

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5501959A (en) * 1989-01-17 1996-03-26 Alamar Biosciences Laboratory, Inc. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US6046021A (en) * 1995-04-12 2000-04-04 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
WO2001000209A1 (en) * 1999-06-29 2001-01-04 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
WO2001081920A2 (en) * 2000-04-20 2001-11-01 Biolog, Inc. Comparative phenotype analysis for assessment of biologically active compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AUBEL DOMINIQUE ET AL: "Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics", JOURNAL OF ANTIBIOTICS (TOKYO), vol. 54, no. 1, January 2001 (2001-01-01), pages 44 - 55, XP001160773, ISSN: 0021-8820 *
FISCHER AB: "Gentamycin as a bacteriocidal antibiotic in tissue culture", MED. MICROBIOL. IMMUNOL. (BERL.), vol. 161, no. 1, 1975, pages 23 - 39, XP008027169 *
SIMALA-GRANT J L ET AL: "Antibiotic susceptibility of attached and free-floating Helicobacter pylori.", THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. ENGLAND MAY 2001, vol. 47, no. 5, May 2001 (2001-05-01), pages 555 - 563, XP002268772, ISSN: 0305-7453 *

Also Published As

Publication number Publication date
DE10235967A1 (en) 2004-02-26
AU2003255282A1 (en) 2004-02-25
WO2004015416A2 (en) 2004-02-19
DE10235967B4 (en) 2005-09-08

Similar Documents

Publication Publication Date Title
WO2004029219A3 (en) Cell-based rna interference and related methods and compositions
WO2002084250A3 (en) Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
WO2004011611A3 (en) Taci antibodies and uses thereof
AU2003241311A1 (en) Simple catalytic dna biosensors for ions based on color changes
WO2006015209A3 (en) Differentiation of stem cells
WO2005020785A3 (en) Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
WO2005094324A3 (en) Mixed cell diagnostic systems
CA2451985A1 (en) Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
WO2003008622A3 (en) Exponential nucleic acid amplification using nicking endonucleases
WO2002059300A3 (en) Double-stranded rna-mediated gene suppression
WO2005003317A3 (en) Engineered blood vessels
WO2002090539A3 (en) Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
MXPA01011182A (en) Methods, compositions and kits for biological indicator of sterilization.
WO2001085982A3 (en) Mixed cell systems for the detection of viruses
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
WO2003046135A3 (en) Osteopontin-related compositions and methods
WO2004015416A3 (en) Methods for the identification of agents with anti-microbial action
WO2004022782A3 (en) Compositions and methods for tissue specific or inducible inhibition of gene expression
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2005123913A3 (en) Reversibly modified thermostable enzyme compositions and methods of making and using the same
TR199700796T1 (en) Controlling post-harvest fungal diseases with the use of saprophytic yeast.
WO2003076897A3 (en) Multiplexed analysis of cellular responses using endogenous reporter genes
WO2003035889A3 (en) Compositions and methods for bacteria detection
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2003288621A1 (en) Rna bioassay

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP